| |
|
|
|
ASLAN Pharmaceuticals Limited  
|
|
3.22 0.07 (0.02%) |
07-19 16:00 |
|
Open: |
3.1199 |
Pre close: |
3.15 |
Target:
|
4.06
|
|
High: |
3.22 |
Low: |
3.1032 |
Resistance:
|
3.48
3.90
|
|
Volume: |
5,043 |
Market Cap: |
107M |
Support:
|
2.80
2.33
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.22
 |
MACD |
MACD(12,26):
|
-0.06 |
|
MA(20): |
3.39 |
Signal(12,26,9): |
-0.03 |
|
MA(100): |
3.73  |
Stochastic Oscillator |
%K(14,3):
|
23.04 |
|
MA(250): |
4.99 |
%D(3): |
23.58 |
|
Average Volume(K) |
3-Month: |
1454
|
52-Week |
High:
|
8.85 |
|
10-Days: |
793 |
Low: |
2.51 |
|
RSI |
RSI(14):
|
45.24 |
Change(%): |
-58.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.170 |
Return on Equity (ttm) |
-144.4 |
Shares Out. (M) |
32.05 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-48.4 |
Shares Float (M) |
28.14 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
9.35 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1 |
|
Book Value (p.s.) |
0.820 |
EBITDA (p.s.) |
0.000 |
P/E |
-2.75 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.93 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
